-
Herpes Simplex Market Poised for Substantial Growth by 2034, According to DelveInsight | Maruho, AiCuris, Starpharma
19 Dec 2024 11:04 GMT
… RedBioTec, TGV-Laboratories, Sanofi, Starpharma, and others, are actively … , Maruho, AiCuris, Sanofi, GlaxoSmithKline, Starpharma, ReceptoPharm, and more.
• Emerging … , Maruho, AiCuris, Sanofi, GlaxoSmithKline, Starpharma, ReceptoPharm, and more.
• Key …
-
Medicxi and Starpharma create Petalion Therapeutics to develop novel dendrimer-based treatments (ASX Announcement)
09 Apr 2024 17:21 GMT
… therapies in oncology, utilising Starpharma’s proprietary DEP dendrimer platform … created by Medicxi and Starpharma. Leveraging Starpharma’s world-leading technology … strategic partnership, which combines Starpharma’s expertise in developing dendrimer …
-
Starpharma partners with UK investment firm to create Petalion Therapeutics
09 Apr 2024 06:57 GMT
… novel oncology drug candidate. Starpharma will license particular intellectual property … created by Medicxi and Starpharma. Leveraging Starpharma’s world-leading technology … strategic partnership, which combines Starpharma’s expertise in developing dendrimer …
-
Starpharma to establish UK joint venture
08 Apr 2024 19:32 GMT
… conjugate therapies in oncology, utilising Starpharma’s proprietary DEP dendrimer platform … novel oncology drug candidate.
Starpharma will license intellectual property to … strategic partnership, which combines Starpharma’s expertise in developing dendrimer …
-
Medicxi and Starpharma to develop dendrimer-based cancer treatments
08 Apr 2024 10:07 GMT
… treatments.
The collaboration leverages Starpharma’s DEP dendrimer platform technology … dendrimer-drug conjugate therapies.
Starpharma’s contribution to the partnership … strategic partnership, which combines Starpharma’s expertise in developing dendrimer …
-
Starpharma announces creation of Petalion Therapeutics to develop dendrimer-drug conjugates for cancer
08 Apr 2024 14:40 GMT
Cancer
Starpharma Holdings Ltd. has entered into … conjugate therapies in oncology, utilizing Starpharma’s proprietary DEP dendrimer platform …
-
Australia's Starpharma and UK-based Medicxi create Petalion Therapeutics to develop novel dendrimer-based treatments
08 Apr 2024 09:50 GMT
Australia-based Starpharma has entered into a strategic … conjugate therapies in oncology, utilising Starpharma’s proprietary DEP dendrimer platform … a novel oncology drug candidate. Starpharma will license certain intellectual property …
-
Medicxi, Starpharma create Petalion with $25M round
09 Apr 2024 23:56 GMT
-
ASX Health Stocks: Starpharma suffers setback as FDA rejects appeal, shares down 10pc
19 Feb 2024 01:22 GMT
… nasal spray, SPONTAN
Starpharma suffers FDA setback
Starpharma (ASX:SPL) fell -10% … relating to recent product approvals.
Starpharma had engaged highly experienced regulatory … US market in the future, Starpharma will not prioritise conducting another …
-
Starpharma says Viraleze shows antiviral efficacy in COVID-19 patients
30 Jan 2024 07:46 GMT
Starpharma (ASX:SPL) has … infection control of populations.”
Starpharma’s CEO Cheryl Maley said … These results are consistent with Starpharma’s nonclinical studies, which … viruses, including human coronaviruses.
“Starpharma is grateful to the Principal …
About
© 1995-2025